Welcome to the Hawaii Chapter of the American College of Cardiology2026 Conference Click here to learn about our annual Chapter meeting April 25, 2026 Click here to download the flyer |
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Healthy Versions of Low-Carb and Low-Fat Diets Linked to Better CV and Metabolic HealthThe quality of a low-carbohydrate or low-fat diet may matter more than the amount of carbohydrates or fat consumed when it comes to reducing heart disease risk, according to a study published Feb. 11 in JACC. Researchers found that versions of both diet patterns emphasizing macronutrients from healthy foods were associated with a lower risk […]
- BASEL-PMI: Does Cardiologist Evaluation in Patients With PMI Reduce CV Risk?One year after major noncardiac surgery, patients who received an evaluation for perioperative myocardial infarction/injury (PMI) by a cardiologist had a lower risk of all-cause mortality and major cardiac events, according to a multicenter prospective study published Jan. 30 in EHJ. The findings suggest that interdisciplinary management may improve postoperative outcomes in patients with PMI.
- COACT 5 Year Data: Similar Survival With Immediate vs. Delayed Coronary Angiography in OHCA SurvivorsAt five years, survival was comparable between immediate and delayed angiography with no clinical benefit or harm in patients without ST-segment elevation resuscitated from out-of-hospital cardiac arrest (OHCA), according to new results from the randomized COACT trial published Feb. 4 in JACC.
- Substantial Hospital-Level Variation in Immediate Coronary Angiography Among Patients With STEMI and OHCA | NCDR StudyAmong patients presenting with both out-of-hospital cardiac arrest (OHCA) and STEMI, substantial hospital-level variation was found in providing immediate coronary angiography (CA), according to a Brief Report published Feb. 11 in JACC.
- ACCEL Lite: VESALIUS-CV Trial: Effect of Evolocumab in Patients at CV Risk without Prior MI or StrokeIn this interview, Nanette Kass Wenger MD, MACC and Erin A. Bohula, MD, FACC discuss the VESALIUS-CV Trial: Effect of Evolocumab in Patients at CV Risk without Prior MI or Stroke.


